Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II

Escherichia coli O157:H7 strains have been implicated as etiologic agents in food-borne outbreaks of hemorrhagic colitis and the hemolytic-uremic syndrome. A prototype E. coli O157:H7 strain, designated 933, produces Shiga-like toxin I (SLT-I) and SLT-II and harbors a 60-MDa plasmid. In a previous study, streptomycin-treated mice were fed 933 together with a derivative cured of the 60-MDa plasmid (designated 933cu). Strain 933cu colonized poorly, but in approximately one-third of the animals, an isolate of 933cu was obtained from the feces that had regained the ability to colonize well. This isolate, designated 933cu-rev, killed all of the animals when fed alone to mice. In this investigation, two types of experiments were done to assess whether SLT-I, SLT-II, or both contributed to the death of mice fed 933cu-rev. (i) Mice were pretreated with monoclonal antibodies to SLT-I, SLT-II, SLT-I and SLT-II, or cholera toxin (as a control) before infection with 933cu-rev. (ii) Mice were fed either an E. coli K-12 strain carrying cloned SLT-I genes or the same K-12 strain carrying cloned SLT-II genes. The results of both types of experiments indicated that the deaths of the orally infected mice were due solely to SLT-II. Extensive histological and selected electron microscopic examinations of various tissues from the infected animals suggested that death was due to acute renal cortical tubular necrosis consistent with toxic renal damage. These data indicate a critical role for SLT-II, but not SLT-I, in renal damage associated with E. coli O157:H7 infection of streptomycin-treated mice.

[1]  A. O’Brien,et al.  Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 , 1990, Infection and immunity.

[2]  J. Samuel,et al.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants , 1990, Infection and immunity.

[3]  S. Ostroff,et al.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.

[4]  M. P. Jackson,et al.  In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity , 1989, Infection and immunity.

[5]  H. Mantsch,et al.  Interaction of Shigella toxin with globotriaosyl ceramide receptor-containing membranes: a fluorescence study. , 1989, Biochemical and biophysical research communications.

[6]  T. Barrett,et al.  Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. , 1989, The Journal of infectious diseases.

[7]  M. Kyogashima,et al.  Escherichia coli K99 binds to N-glycolylsialoparagloboside and N-glycolyl-GM3 found in piglet small intestine. , 1989, Archives of biochemistry and biophysics.

[8]  S. Saxena,et al.  Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. , 1989, The Journal of biological chemistry.

[9]  C. Lingwood,et al.  Verotoxin receptor glycolipid in human renal tissue. , 1989, Nephron.

[10]  L. Pickering,et al.  Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. , 1988, The Journal of pediatrics.

[11]  L. Becker,et al.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.

[12]  M. P. Jackson,et al.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine , 1988, Journal of bacteriology.

[13]  J. H. Green,et al.  Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies , 1988, Infection and immunity.

[14]  C. Lingwood,et al.  Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. , 1988, Biochemical and biophysical research communications.

[15]  L. M. Sung,et al.  Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1 , 1988, Journal of bacteriology.

[16]  R. Holmes,et al.  Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli , 1988, Infection and immunity.

[17]  T. Yutsudo,et al.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.

[18]  N. Strockbine,et al.  Cloning of genes for production of Escherichia coli Shiga-like toxin type II , 1987, Infection and immunity.

[19]  M. P. Jackson,et al.  Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933 , 1987 .

[20]  C. Lingwood,et al.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.

[21]  J. Brown,et al.  Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. , 1987, The Journal of biological chemistry.

[22]  M. Levine,et al.  A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells , 1987, Infection and immunity.

[23]  J. Wells,et al.  Production of Shiga-like toxin by Escherichia coli. , 1986, The Journal of infectious diseases.

[24]  R. Holmes,et al.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities , 1986, Infection and immunity.

[25]  G. Keusch,et al.  Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin- binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide , 1986, The Journal of experimental medicine.

[26]  C. Pai,et al.  Experimental infection of infant rabbits with verotoxin-producing Escherichia coli , 1986, Infection and immunity.

[27]  R. Holmes,et al.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli , 1985, Infection and immunity.

[28]  H. Lior,et al.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.

[29]  R. Holmes,et al.  Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. , 1984, Science.

[30]  L. Enquist,et al.  Experiments With Gene Fusions , 1984 .

[31]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[32]  S. Gorbach,et al.  PURIFICATION OF SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE TOXIN FROM ESCHERICHIA COLI 0157:H7 STRAIN ASSOCIATED WITH HAEMORRHAGIC COLITIS , 1983, The Lancet.

[33]  J. Wells,et al.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype , 1983, Journal of clinical microbiology.

[34]  J. Wells,et al.  Hemorrhagic colitis associated with a rare Escherichia coli serotype. , 1983, The New England journal of medicine.

[35]  S. Formal,et al.  ESCHERICHIA COLI 0157:H7 STRAINS ASSOCIATED WITH HAEMORRHAGIC COLITIS IN THE UNITED STATES PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA) LIKE CYTOTOXIN , 1983, The Lancet.

[36]  V. Cabelli,et al.  The effect of plasmid gene expression on the colonizing ability of E. coli HS in mice. , 1982, Recombinant DNA technical bulletin.

[37]  F. Bolivar,et al.  Construction and characterization of new cloning vehicles. VI. Plasmid pBR329, a new derivative of pBR328 lacking the 482-base-pair inverted duplication. , 1982, Gene.

[38]  R. Yu,et al.  Gangliosides: structure, isolation, and analysis. , 1982, Methods in enzymology.

[39]  J. Magnani,et al.  Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms. , 1980, Analytical biochemistry.

[40]  D. Griffin,et al.  Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography , 1980, Infection and immunity.

[41]  J. Dalrymple,et al.  Quantitative microtiter cytotoxicity assay for Shigella toxin , 1980, Journal of clinical microbiology.

[42]  Y. Hirota,et al.  On the process of cellular division in Escherichia coli: a mutant of E. coli lacking a murein-lipoprotein. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Recombinant DNA Research Guidelines. , 1976, Federal register.